Current Report Filing (8-k)
August 14 2013 - 6:02AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
|
|
|
Date of Report (Date of Earliest Event Reported): |
|
August 14, 2013 |
STAAR Surgical
Company
__________________________________________
(Exact name of registrant
as specified in its charter)
|
|
|
Delaware |
0-11634 |
95-3797439 |
(State or other jurisdiction |
(Commission |
(I.R.S. Employer |
of incorporation) |
File Number) |
Identification No.) |
|
|
|
1911 Walker Ave, Monrovia, California |
|
91016 |
(Address of principal executive offices) |
|
(Zip Code) |
|
|
|
Registrant’s telephone number, including area code: |
|
626-303-7902 |
Not Applicable
______________________________________________
Former name or former address, if changed
since last report
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
¨Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01 Regulation
FD Disclosure.
STAAR
Surgical Company’s President and Chief Executive Officer, Barry Caldwell, will give a presentation to investors on
August 14, 2013. A copy of the slide presentation Mr. Caldwell will use in his presentation is furnished as Exhibit
99.1 to this Report, and is incorporated herein by this reference.
The
information furnished herewith pursuant to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed to be
“filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report shall not be incorporated
by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the
date of this Current Report, regardless of any general incorporation language in the filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit No. |
Description |
99.1 |
Slide Presentation dated August 14, 2013. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
STAAR
Surgical Company
|
|
August 14, 2013 |
By: |
/s/ Barry G. Caldwell |
|
|
Barry G. Caldwell |
|
|
President and Chief Executive Officer |
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Jun 2024 to Jul 2024
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Jul 2023 to Jul 2024